Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 09, 2024

BUY
$0.7 - $1.31 $7,000 - $13,100
10,000 Added 32.26%
41,000 $34,000
Q3 2023

Oct 13, 2023

BUY
$1.25 - $3.0 $1,250 - $3,000
1,000 Added 3.33%
31,000 $42,000
Q2 2023

Jul 24, 2023

BUY
$1.73 - $2.79 $4,325 - $6,975
2,500 Added 9.09%
30,000 $75,000
Q1 2023

Apr 20, 2023

BUY
$1.43 - $4.24 $39,325 - $116,600
27,500 New
27,500 $62,000

Others Institutions Holding VAXX

About Vaxxinity, Inc.


  • Ticker VAXX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 112,150,000
  • Description
  • Vaxxinity, Inc., a biotechnology company, focuses on developing product candidates for human use in the fields of neurology and coronaviruses in the United States. The company engages in developing UB-311 that targets toxic forms of aggregated amyloid-b in the brain to fight Alzheimer's disease (AD) that is in phase 2 clinical trial; UB-312 that...
More about VAXX
Track This Portfolio

Track Blue Zone Wealth Advisors, LLC Portfolio

Follow Blue Zone Wealth Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Blue Zone Wealth Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Blue Zone Wealth Advisors, LLC with notifications on news.